HeartBeam to Present at Upcoming Investor Conferences
September 29 2022 - 8:31AM
Business Wire
HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology
company that has developed the first and only 3D-vector ECG
platform for heart attack detection anytime, anywhere, will present
at the Dawson James Small Cap Growth Conference being held at the
Wyndham Grand Hotel in Jupiter, FL on October 12, 2022, and The
ThinkEquity Conference taking place at the Mandarin Oriental Hotel
in New York City on October 26, 2022.
HeartBeam Chief Executive Officer and Founder Branislav Vajdic,
PhD, Chief Financial Officer Rick Brounstein, and Chief Business
Officer Jon Hunt, PhD, will conduct in-person one-on-one meetings
and deliver the Company’s presentations which can be viewed live
and via replay at the webcast link below and will also be available
on the HeartBeam investor relations website at
ir.heartbeam.com.
Dawson James Small Cap Growth Conference Date: October
12, 2022 Location: Jupiter, FL Presentation Time: October 12, 2022,
at 10:00 am ET (7:00 am PT) in TRACK 2 - Preserve Ballroom B
Webcast: https://wsw.com/webcast/dawson7/beatw/2191545 Format:
In-person 1x1’s and Presentations Speakers: Chief Executive Officer
and Founder Branislav Vajdic, PhD, Chief Financial Officer Rick
Brounstein, Chief Business Officer Jon Hunt, PhD Conference
Website: Click here
The ThinkEquity Conference Date: October 26, 2022
Location: New York City Presentation Time: October 26, 2022, at
4:30 pm ET (1:30 pm PT) in South Salon II Webcast:
https://wsw.com/webcast/tep23/beatw/1805130 Format: In-person 1x1’s
and Presentations Speakers: Chief Executive Officer and Founder
Branislav Vajdic, PhD, Chief Financial Officer Rick Brounstein,
Chief Business Officer Jon Hunt, PhD Conference Website: Click
here
For more information on the Dawson James Small Cap Growth or
ThinkEquity Conferences, or to schedule a one-on-one meeting with
HeartBeam management, please contact your conference representative
or you may also email your request to BEAT@mzgroup.us or call Chris
Tyson at (949) 491-8235.
About HeartBeam, Inc.
HeartBeam, Inc. (NASDAQ: BEAT) is a cardiac technology company
that has developed the first and only 3D-vector ECG platform for
heart attack detection anytime, anywhere. By applying a suite of
proprietary algorithms to simplify vector electrocardiography
(VECG), the HeartBeam platform enables patients and their
clinicians to determine if symptoms are due to a heart attack,
quickly and easily, so care can be expedited, if required.
HeartBeam has two patented products in development. HeartBeam AIMI™
is software for acute care settings that provides a 3D comparison
of baseline and symptomatic 12-lead ECG to more accurately identify
a heart attack. HeartBeam AIMIGo™ is the first and only credit
card-sized 12-lead output ECG device coupled with a smart phone app
and cloud-based diagnostic software system to facilitate remote
heart attack detection. HeartBeam AIMI and AIMIGo have not yet been
cleared by the US Food and Drug Administration (FDA) for marketing
in the USA or other geographies. For more information, visit
HeartBeam.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220929005471/en/
Investor Relations Contact: Chris Tyson Executive Vice
President MZ North America Direct: 949-491-8235 BEAT@mzgroup.us
www.mzgroup.us
Media Contact: Capwell Communications
media@capwellcomm.com 949-999-3303
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Aug 2024 to Sep 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Sep 2023 to Sep 2024